NASDAQ: AIRSAirsculpt Technologies Inc Stock
$7.53+0.07 (+0.94%)
Updated May 26, 2023
AIRS Price
$7.53
Fair Value Price
N/A
Market Cap
$427.59M
52 Week Low
$2.69
52 Week High
$11.75
P/E
-30.12x
P/B
5.68x
P/S
1.63x
PEG
N/A
Dividend Yield
5.44%
Revenue
$175.06M
Earnings
-$14.00M
Gross Margin
62.2%
Operating Margin
-0.92%
Profit Margin
-8%
Debt to Equity
1.79
Operating Cash Flow
$24M
Beta
1.96
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
AIRS Overview
AirSculpt Technologies, Inc., provides body contouring procedure services through its network of service centers in the U.S. Its AirSculpt procedure removes unwanted fat in a minimally invasive procedure. The company also provides fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. AirSculpt was founded in 2012 and is headquartered in Miami Beach, FL.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AIRS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AIRS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AIRS is poor value based on its book value relative to its share price (5.68x), compared to the US Medical Care Facilities industry average (4.41x)
P/B vs Industry Valuation
AIRS is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more AIRS due diligence checks available for Premium users.
Be the first to know about important AIRS news, forecast changes, insider trades & much more!
AIRS News
Valuation
AIRS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-30.12x
Industry
8.74x
Market
54.23x
AIRS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.68x
Industry
4.41x
AIRS is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AIRS's financial health
Profit margin
Revenue
$45.8M
Net Income
-$14.0k
Profit Margin
0%
AIRS's Earnings (EBIT) of -$1.61M... subscribe to Premium to read more.
Interest Coverage Financials
AIRS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$209.5M
Liabilities
$134.3M
Debt to equity
1.79
AIRS's short-term liabilities ($21.52M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AIRS's long-term liabilities ($112.78M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AIRS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$6.2M
Investing
-$3.8M
Financing
-$737.0k
AIRS's operating cash flow ($23.59M)... subscribe to Premium to read more.
Debt Coverage Financials
AIRS vs Medical Care Facility Stocks
Airsculpt Technologies Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.